Clinical trials sponsored by National University Hospital, Singapore
9
Recruiting trials
15
Conditions studied
Phase breakdown
Phase 1 1Phase 2 2Phase 3 1Not applicable 6
Conditions studied
Recruiting trials led by National University Hospital, Singapore
- Antenatal Myo-inositol Supplementation in Pre-existing Diabetes
- Liquid Biopsy-Based Pre-Screening to Streamline LDCT Lung Cancer Screening in High-Risk Individuals
- Neoadjuvant ADG126 and Pembrolizumab in Locally Advanced Colorectal Cancer
- Osimertinib for Advanced EGFR-positive NSCLC Patients
- Potential of Interface Care Models to Deliver More Appropriate Care to Patients With Acute Medical Illness
- Redirecting Immune, Lipid and Metabolic Drivers of Early Cardiovascular Disease: The RESET Cohort Study
- Reducing Inflammatory Syndrome in Surgery - Colorectal (RISIS-CR) Trial
- Selinexor & Talazoparib in Advanced Refractory Solid Tumors; Advanced/Metastatic Triple Negative Breast Cancer (START)
- Use of a Digital Psychotherapeutic App to Reduce Symptom Burden in Dermatology Patients
Common questions
How many trials is National University Hospital, Singapore recruiting for?
National University Hospital, Singapore is the lead sponsor of 9 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.